Ruth Djaldetti

Best Publications

• VPS35 Mutations in Parkinson Disease

  Carles Vilariño-Güell;Christian Wider;Owen A. Ross;Justus C. Dachsel

  1056
  Citations

• The natural history of multiple system atrophy: a prospective European cohort study

  Gregor K Wenning;Felix Geser;Felix Geser;Florian Krismer;Klaus Seppi

  590
  Citations

• The mystery of motor asymmetry in Parkinson's disease.

  Ruth Djaldetti;Ilan Ziv;Eldad Melamed

  466
  Citations

• Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

  Miquel Vila;Vernice Jackson-Lewis;Slobodanka Vukosavic;Ruth Djaldetti

  455
  Citations

• Increased plasma endothelin-1 in acute ischemic stroke.

  I Ziv;G Fleminger;R Djaldetti;A Achiron

  375
  Citations

• Quantitative measurement of pain sensation in patients with Parkinson disease

  R. Djaldetti;A. Shifrin;Z. Rogowski;E. Sprecher

  372
  Citations

• The parkinsonian toxin MPTP: action and mechanism.

  Serge Przedborski;Vernice Jackson-Lewis;Ruth Djaldetti;Gabriel Liberatore

  343
  Citations

• Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry

  Martin Köllensperger;Felix Geser;Jean Pierre Ndayisaba;Sylvia Boesch

  303
  Citations

• Camptocormia (bent spine) in patients with Parkinson's disease--characterization and possible pathogenesis of an unusual phenomenon.

  Ruth Djaldetti;Ronit Mosberg-Galili;Haza Sroka;Doron Merims

  303
  Citations

• Red flags for multiple system atrophy

  Martin Köllensperger;Felix Geser;Klaus Seppi;Michaela Stampfer-Kountchev

  274
  Citations

• Gastric emptying in Parkinson's disease Patients with and without response fluctuations

  Ruth Djaldetti;Jack Baron;Ilan Ziv;Eldad Melamed

  267
  Citations

• Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study.

  Itay Lotan;Therese A. Treves;Yaniv Roditi;Ruth Djaldetti

  246
  Citations

• Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: a double-blind study as adjunctive therapy to levodopa

  J M Rabey;I Sagi;M Huberman;E Melamed

  229
  Citations

• [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.

  Mordechai Lorberboym;Therese A. Treves;Eldad Melamed;Yair Lampl

  191
  Citations

• IL-1β, IL-2, IL-6 and TNF-α production by peripheral blood mononuclear cells from patients with Parkinson's disease

  H. Bessler;R. Djaldetti;H. Salman;M. Bergman

  181
  Citations

• Developmental cell death in dopaminergic neurons of the substantia nigra of mice.

  Vernice Jackson-Lewis;Miquel Vila;Ruth Djaldetti;Christelle Guegan

  171
  Citations

• Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA study group (EMSA SG)

  Felix Geser;Gregor K. Wenning;Klaus Seppi;Michaela Stampfer‐Kountchev

  168
  Citations

• Skin biopsy for assessment of autonomic denervation in Parkinson's disease.

  R. Dabby;R. Djaldetti;M. Shahmurov;T. A. Treves

  144
  Citations

• 123I-FP-CIT SPECT Imaging of Dopamine Transporters in Patients with Cerebrovascular Disease and Clinical Diagnosis of Vascular Parkinsonism

  Mordechai Lorberboym;Ruth Djaldetti;Eldad Melamed;Menahem Sadeh

  135
  Citations

• Health-related quality of life in multiple system atrophy

  Anette Schrag;Felix Geser;Michaela Stampfer-Kountchev;Klaus Seppi

  133
  Citations